Cargando…
Between two storms, vasoactive peptides or bradykinin underlie severity of COVID‐19?
Coronavirus disease 2019 (COVID‐19), caused by severe acute respiratory syndrome coronavirus 2 (SARS‐CoV‐2), continues to be a world‐wide pandemic with overwhelming socioeconomic impact. Since inflammation is one of the major causes of COVID‐19 complications, the associated molecular mechanisms have...
Autor principal: | Karamyan, Vardan T. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7941673/ https://www.ncbi.nlm.nih.gov/pubmed/33687143 http://dx.doi.org/10.14814/phy2.14796 |
Ejemplares similares
-
A new storm on the horizon in COVID-19: Bradykinin-induced vascular complications
por: McCarthy, Cameron G., et al.
Publicado: (2021) -
D-Arg(0)-Bradykinin-Arg-Arg, a Latent Vasoactive Bradykinin B(2) Receptor Agonist Metabolically Activated by Carboxypeptidases
por: Bachelard, Hélène, et al.
Publicado: (2018) -
Role of vasoactive intestinal peptide in osteoarthritis
por: Jiang, Wei, et al.
Publicado: (2016) -
A mechanistic model and therapeutic interventions for COVID-19 involving a RAS-mediated bradykinin storm
por: Garvin, Michael R, et al.
Publicado: (2020) -
The role of peptidase neurolysin in neuroprotection and neural repair after stroke
por: Karamyan, Vardan T.
Publicado: (2020)